In conclusion, this study shows that the combination of TRAIL and bortezomib efficiently induces apoptosis through both the death receptor and mitochondrial pathway in TRAIL-resistant HPV+ HNSCC cells and enhances TRAIL-mediated cell death in HPV− cells. The gene discussed is TNFSF10; the disease is head and neck squamous cell carcinoma.